American Scientific Resources Inc. (Pink Sheets: ASFX)
American Scientific Resources Inc. (ASFX) is an emerging manufacturer and distributor of next-generation medical products and healthcare supplements sourced from around the globe. Its products are distributed primarily through leading retail drug chains, nationwide medical suppliers, infomercials and online sites. The Company has two reportable operating segments: Heart Smart System Inc., which supplies nutraceutical supplements developed to aid in the prevention of cardiovascular disease; and Kidz-Med Inc., which distributes an innovative line of health and safety-related pediatrics products.
Incorporated in 1990, the Company is based in New Paltz, New York.
|
Share Statistics 18-Aug-09) |
|
2007 |
2008 |
% Chg |
Q1 ’08 |
Q1 ’09 |
% Chg |
|
|
Symbol |
ASFX |
Revenue, $Mn |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
|
Current price |
$0.01 |
Gross marg. |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
|
52wk Range: |
$0.00-$0.02 |
Oper. margin |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
|
Avg Vol (3m): |
46.7M |
Net margin |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
|
Market Cap. |
3.7M |
|
|
|
|
|
|
|
|
Dil. Shares Outst. |
306.61M |
EPS, $ |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
Source: Reuters.com, SEC Filings.
Financial Summary
On May 11, the Company posted its unaudited revenue results for the first quarter ended March 31, 2009. Citing a boost in online sales of the Kidz-Med Thermofocus 5-in-1 Non-Contact Thermometer, Pacifier Medicine Dispenser and other products supplied by Kidz-Med, the development-stage Company stated that it experienced a 15% sales increase with net sales of $263,603 for the first quarter of 2009, as compared to net sales of $229,982 for the first quarter of 2008. The management hopes to have the audit of the 2008 financials and Q1 2009 review completed shortly.
Analyst Consensus
No analysts rate ASFX at this stage of company’s development.
Investment Highlights
Overview
Based in New Paltz, New York, ASFX manufactures and distributes medical products and supplies. It is a holding company for two wholly owned subsidiaries: Kidz-Med Inc. and Heart Smart System.
Kidz-Med Inc. distributes a leading line of medical and medicine delivery devices for children and sensitive
adults, including the Kidz-Med Thermofocus® 5-in-1, the world’s first clinical non-contact thermometer. Founded in 1993, this division has grown to become an innovative leader in the pediatric and children’s health and safety products industry. It provides the most revolutionary patented family-friendly products sourced from around the globe to help keep children safe and parents reassured.
Heart Smart System Inc. supplies nutraceutical supplements developed to aid in the prevention of cardiovascular disease.
Market
Market observers estimate that the medical-surgical products distribution industry will continue to grow as the aging U.S. population demand more healthcare services. According to Hoover’s report, the number of Americans over 65 will increase more than 50% between 2000 and 2020. In addition, reports indicate that trends such as the proliferation of medical technology and testing, new pharmacology treatments, as well as the increasing healthcare awareness will positively impact the medical products distribution industry. According to a report by Research and Markets, industry participants and the Health Industry Distributors Association estimate the market size of the acute care, medical-surgical distribution to be approximately $21 billion to $25 billion.
Company Highlights and Recent News
ASFX’s goal is to provide next-generation medical products and healthcare supplements sourced from around the globe. The Company is currently concentrating its efforts toward successful marketing of its next-generation medical products and healthcare supplements, while continuing to locate and acquire unique products that are successfully sold abroad, and introduce and promote them to the North American market.
On August 18, ASFX’s wholly owned subsidiary Kidz-Med announced it has received an initial Purchase Order of the Kidz-Med Thermofocus 5-in-1 Non-contact Thermometers from another distinguished baby specialty retailer, which is expected to hit the customer’s stores this fall.
For the first quarter ended March 31, 2009, the Company reported that sales revenues increased primarily on Kidz-Med Thermofocus 5-in-1, which has been long recommended by doctors throughout the UK, Europe and Asia. This instrument, which uses safe infrared technology, proves to be ideal in diagnosing flu-associated fever since it has absolutely no contact with the skin, making for a completely hygienic and non-invasive experience.
Prior to reporting an update from a new vendor for its flagship product, Kidz-Med said Walgreens intended to cut many SKUs out of its planograms going in to the 2009/2010 year, including the Kidz-Med Thermofocus. Currently, no word has been given as to when reorders might resume. However, ASFX CEO Christopher Tirotta stated that the Company has a strong working relationship with Walgreens, and that the latter has indicated interest in future products that Kidz-Med would like to bring to market.
The Company yesterday announced has become the exclusive seller of the world’s only FDA-approved home needle destruction device. On August 19, the Company announced it has obtained from Safeguard Medical Technologies LLC exclusive worldwide rights to sell and market home Needle Destruction Devices (NDD) known as the Disintegrator(TM) and the Disintegrator Plus(TM). According to the Company’s press release, all current and future sales and contracts worldwide have been granted to the Company. It plans to introduce the product commercially in the fall of 2009.
Technical Analysis
Source: http://stockcharts.com/h-sc/ui
ASFX trades above its 13-day moving average. This generally bullish sign is significant because the moving average are also positively trending.
The MACD for ASFX currently indicates a strong bullish signal. The MACD is above the signal line, a 9-day moving average of the MACD. The MACD is also above the critical level of 0, which implies the past price action had been positive. ASFX’s above-normal volatility is indicated by its increased distance between its upper and lower bands. ASFX is trading above its Bollinger Band, and relative to recent price action, this signals the stock is currently overextended.
Comparative Analysis
|
Company Name |
Ticker |
Price per |
Mrkt. Cap. |
P/E |
P/S |
|||
|
Aug-19-2009 |
symbol |
Share, $ |
$ Mn |
2009 |
2010 |
2009 |
2010 |
|
|
McKesson Corp. |
MCK. |
54.97 |
14.63B |
17.35 |
– |
0.14 |
– |
|
|
Amerisource Bergen Corp. |
ABC |
20.83 |
6.19B |
13.13 |
– |
0.09 |
– |
|
|
Cardinal Health Inc. |
CAH |
34.98 |
12.61B |
10.54 |
– |
0.13 |
n/a |
|
|
Industry Median |
|
|
|
13.67 |
n/a |
0.12 |
n/a |
|
|
American Scientific Resources Inc. |
ASFX |
0.01 |
2.91M |
n/a |
n/a |
n/a |
n/a |
|
Insider Trading Activity
|
NET SHARE PURCHASE ACTIVITY |
|||||||
|
|
|
|
|||||
|
Insider Purchases – Last 6 Months |
|||||||
|
|
Shares |
Trans |
|
||||
|
Purchases |
n/a |
n/a |
|
||||
|
Sales |
n/a |
n/a |
|
||||
|
Net Shares Purchased |
n/a |
n/a |
|
||||
|
Total Insider Shares Held |
n/a |
n/a |
|
||||
|
% Net Shares Purchased |
n/a |
n/a |
|
||||
|
|
|||||||
|
|
|
|
|||||
|
Net Institutional Purchases – Prior Qtr to Latest Qtr |
|||||||
|
|
Shares |
|
|||||
|
Net Shares Purchased (Sold) |
n/a |
|
|||||
|
% Change in Institutional Shares Held |
n/a |
|
|||||
|
|
|||||||
|
|
Data provided by Thomson Financial |
|
|||||
|
|
|||||||
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
About StockPreacher.com
StockPreacher.com is committed to producing the highest-quality insight and analysis of small cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.
StockPreacher Disclaimer
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockPreacher.com is a wholly owned subsidiary of BlueWave Advisors. BlueWave Advisors has not been compensated, and holds no positions in any of the stocks mentioned in this article.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

